Cannavalon Biosciences, Inc. is a vertically integrated, Northern-California cannabis company based in Santa Rosa, California that operates growing and processing facilities in the world-famous, Sonoma County appellation. Cannavalon’s core disciplines include cannabinoid research, science-to-sale operations, and product validation. Their expertise is derived from a decade (since 2007) of growing and oil extraction experience and five years (since 2012) of cannabinoid research and testing through their mergers with Vinea Labs, Inc. and Elysium Wellness Non-Profit. 


We operate transparently within our community and adhere to the medical and recreational cannabis legal structures put in place by the State of California and County and City jurisdictions.




The mission is to be the leader in the production and marketing of the most efficacious, consistent and non-toxic medicinal cannabis products. Cannavalon’s product line is proven, trusted and ready. 


When we say ready, we mean it. The research, development, and testing has been

accomplished over the last 7 years of patient use and results. 


Medical Cannabis


Under the Compassionate Use Act of 1996 (Proposition 215), patients holding valid medical cannabis registrations may purchase cannabis medicinal products from licensed California medical dispensaries. A vast wealth of research papers has demonstrated that medical cannabis is an effective agent or has shown promise in treating pain, muscle spasms, headaches, anxiety, nausea, vomiting, depression, addiction therapy (e.g. opioids), incontinence, cramps, panic attacks, diarrhea, itching, sleep, relaxation, appetite, appetite suppression, concentration, energy and many others. 



“Let food be thy medicine”



A nutraceutical is a food offering medicinal benefit and is “unregulated” (non-pharmaceutical). With the passage of Proposition 64 (recreational legalization) in California, cannabis-based nutraceuticals may soon find their way into pharmacies and health food stores in discrete, one-a-day form factors (e.g. gummy bears, capsule, tablet, powder) or into mainstream supermarkets embedded in common food products (“functional foods”) like cooking and salad oils, candy, cakes, soda, milk, wine, bread, sauces, etc. These “for adult” nutraceuticals will offer an alternative to pill popping by integrating medicinal benefits into daily food regiments.

A dietary supplement is a product intended for ingestion that contains a "dietary ingredient" that adds further nutritional value to (supplement) the diet. A "dietary ingredient" may be one, or any combination, of the following substances: a vitamin, a mineral, an herb or other botanical. As an herb and a botanical, cannabis falls squarely into this definition. It is also loaded with vitamins, minerals, omega-3 and omega-6 fatty acids, and antioxidants.

Steve Mezak, Chief Executive Officer, Founder

Mezak spent over 30 years in Silicon Valley in multiple executive roles thru three major acquisitions (Aspect Development, which sold to i2 for $9 Billion, Digital Market, sold to Agile Software for $75 Million and Accelerance in 2019) and provided expertise beyond software development to sales, marketing and global business strategy.


Paul Swanson, Chief Operating Officer, Chief Technology Officer, Founder

Mr. Swanson is an entrepreneur, visionary, innovator and humanitarian whose background ranges from construction management,  real estate development, agricultural production and cannabis.  With his passion to discover alternative solutions to children’s health problems through cannabinoid research, Paul has emerged as an expert in cannabis genetics, growing, harvesting, extraction and formulation. Since 2013, Paul has been working with special needs families who were using various CBD products with limited and short term success, and have now given them a substantial baseline for healing their children with Elysium Medicinals.

Bill Arnold, MBA, Cannavalon Advisor

Mr. Arnold has spent much of his career focused on successfully preparing and managing many of his companies through sale (3) and IPO’s (1). As a former EVP, President and CEO in industries as varied as computer leasing, banking software and investment management, Mr. Arnold has managed operations of up to 420 employees and has turned multiple companies from loss to profit during his tenure. A major highlight of his career was his direct participation in the sale of U.S. Portfolio Leasing, at the time the largest, publicly-traded leasing company in the United States, to Ford Motor Company.

Please reload

Cannavalon Biosciences, Inc.  Santa Rosa, California 95404

  • Google+ - White Circle
  • White Twitter Icon
  • White Instagram Icon
  • White Facebook Icon

© 2019 Cannavalon Biosciences, Inc.  All Rights Reserved.